New horizons in non-small-cell lung cancer patients with ipsilateral pleural dissemination (M1a): review of the literature.
Ontology highlight
ABSTRACT: Non-small cell lung cancer (NSCLC) with ipsilateral pleural dissemination (pM1a) is generally contraindicated for surgery owing to the extremely poor survival. However, some studies have demonstrated that primary tumor resection (PTR) may prolong the survival of these patients. Besides, with the development of systemic therapy, it is still hard to decide the best therapy model for pM1a patients. Thus, we reviewed essential studies about NSCLC with pleural disease and summarized the progress of new techniques in recent years, trying to provide promising new horizons about the management of pM1a patients. Firstly, we suggest performing PTR for highly selected pM1a patients, combined with appropriate systemic therapies and follow-up strategies. Secondly, hyperthermic intrathoracic chemotherap
SUBMITTER: Li H
PROVIDER: S-EPMC8263880 | biostudies-literature | 2021 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA